AMEA Rewards Director
Opella is seeking an AMEA Rewards Director based in Singapore to lead the regional rewards function. This role involves managing a team, shaping global rewards strategy, and supporting the Indian Nomination & Remuneration Committee. You will oversee compensation, benefits, performance management, and incentive plans for the AMEA region, working closely with various business and P&C teams. The position requires strong expertise in reward leadership, numeracy, and change management.
50k new jobs listed every day. Install TAL to find more jobs like this.
Experience
10+ years
Function
Human Resources
Work mode
Onsite, Singapore
Company
Tier 2
What you will work on
Opella is seeking an AMEA Rewards Director based in Singapore to lead the regional rewards function. This role involves managing a team, shaping global rewards strategy, and supporting the Indian Nomination & Remuneration Committee. You will oversee compensation, benefits, performance management, and incentive plans for the AMEA region, working closely with various business and P&C teams. The position requires strong expertise in reward leadership, numeracy, and change management.
TAL's take
A well-defined senior leadership role in a major global healthcare company with clear regional responsibilities.
The JD provides a clear scope, reporting structure, and specific accountabilities for the rewards function within the AMEA region.
Salaries at Opella
36.0 LPA average
Based on 1 Grapevine salary entries for Opella.
Other roles
10 - 12 years | CL3
36 LPA average
Range: 36 - 36 LPA
Must haves
- 10+ years of experience in Reward leadership roles
- Experience managing teams across borders and cultures
- Strong project management and numeracy skills
- Experience with database systems and excel
- Fluency in English
Tools and skills
About the company
Opella is a large global consumer healthcare company, though not one of the specific tech-focused firms listed in tier 1.
Posts mentioning Opella
How is Opella Health care for joining as SAP cobsultant with 8 + Experince.
Please suggest is Opella Healthcare is good for SAP consultants,i did google getting 50 50 review for pros and cons..
Recent Resignations
Notable executive departures disclosed in the past week include: Both Co-CEOs of Sprinklr (NYSE: CXM — $1.92 billion) “mutually agreed” to depart after five months and fifteen years, respectively; they were replaced by an outside candidate who was previously CEO of Vonage. In February, the company’s Chief Revenue Officer “stepped down” after a little over one year. The company is down ~65% since its June 2021 IPO. CFO of Openlane (NYSE: KAR — $2.11 billion), formerly KAR Auction Services, “will resign from the company effective March 1, 2025 to pursue another opportunity closer to family” after two years. CEO of Sun Communities (NYSE: SUI — $15.6 billion) “has informed the board of his intention to retire in 2025” after 32 years and the board has “established a CEO Succession Planning Committee.” In September 2024, Blue Orca Capital called the company “a mess of egregious executive behavior” and found that Sun’s CEO “received an undisclosed $4 million loan from the family of a supposedly independent Director who sits on the Audit Committee” and also separately “admitted borrowing $700K from a director whose law firm also serves as [Sun’s] general counsel.” Chief Operating Officer of DXC Technology (NYSE: DXC — $3.92 billion) “will be exiting the company” after nearly two years. The company’s General Counsel also departed in March and the company’s former CEO stepped down in December 2023. Chief Commercial Officer of QuidelOrtho Corp (NASDAQ: QDEL — $2.94 billion) was “terminated” after two and a half years along with the company’s Chief Operating Officer who was “terminated” after four years. In February, the company’s CEO was also “terminated” after fifteen years. Chief Accounting Officer of Hippo Holdings (NYSE: HIPO — $701 million) “entered into a separation agreement” after a little over three years. In October, the company’s Chief Revenue Officer also departed after four years. In March 2023, the company replaced Ernst & Young as its a